Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue. [ISBN:0198506732]
Glycerophospholipid catabolism is a crucial biological process that breaks down glycerophospholipids, a major class of lipids found in cell membranes. This breakdown serves several essential functions, including:
1. **Providing energy:** Glycerophospholipid catabolism releases fatty acids and glycerol, which can be used as energy sources by the cell. Fatty acids undergo beta-oxidation to generate ATP, while glycerol can enter glycolysis for further energy production.
2. **Generating signaling molecules:** Certain breakdown products of glycerophospholipids act as signaling molecules involved in various cellular processes. For example, lysophosphatidic acid (LPA) is a potent signaling molecule involved in cell growth, migration, and inflammation.
3. **Remodeling cell membranes:** Glycerophospholipid catabolism is essential for the dynamic remodeling of cell membranes. This process involves the removal of specific glycerophospholipids from the membrane and the insertion of new ones, allowing cells to adapt to changing environmental conditions and maintain membrane fluidity.
The catabolic process can be broadly divided into two main stages:
**Stage 1: Hydrolysis of the phosphodiester bond**
This stage involves the enzymatic hydrolysis of the phosphodiester bond linking the phosphate group to the glycerol backbone of the glycerophospholipid. Phospholipase enzymes, such as phospholipase A, B, C, and D, catalyze this reaction, generating different breakdown products depending on the specific phospholipase involved.
**Stage 2: Breakdown of the fatty acid chains and glycerol**
The fatty acid chains released from the glycerophospholipid molecule can be further broken down by beta-oxidation to produce acetyl-CoA, which can then enter the citric acid cycle for ATP production. Glycerol can be phosphorylated by glycerol kinase and subsequently enter the glycolytic pathway.
**Specific examples of glycerophospholipid catabolic processes:**
* **Phosphatidylcholine hydrolysis:** Phospholipase A2 hydrolyzes phosphatidylcholine, generating lysophosphatidylcholine and fatty acids. Lysophosphatidylcholine can be further broken down by lysophospholipase to yield glycerophosphocholine.
* **Phosphatidylinositol hydrolysis:** Phospholipase C hydrolyzes phosphatidylinositol, generating diacylglycerol (DAG) and inositol triphosphate (IP3). Both DAG and IP3 are important signaling molecules.
* **Phosphatidylethanolamine hydrolysis:** Phospholipase A1 hydrolyzes phosphatidylethanolamine, generating lysophosphatidylethanolamine and fatty acids.
In summary, glycerophospholipid catabolism is a complex and essential biological process that plays crucial roles in energy production, cell signaling, and membrane remodeling. The process involves specific enzymes that catalyze the breakdown of glycerophospholipids into various products that are utilized for different cellular functions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P47712] | Homo sapiens (human) |
Cytosolic phospholipase A2 gamma | A cytosolic phospholipase A2 gamma that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UP65] | Homo sapiens (human) |
Lysophosphatidylserine lipase ABHD12 | A lysophosphatidylserine lipase ABHD12 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8N2K0] | Homo sapiens (human) |
Cytosolic phospholipase A2 beta | A cytosolic phospholipase A2 beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P0C869] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
indomethacin | indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis. Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic; xenobiotic metabolite |
1,6-bis(cyclohexyloximinocarbonyl)hexane | 1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase | carbamate ester; organonitrogen compound | |
ici 204,219 | zafirlukast: a leukotriene D4 receptor antagonist | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
dronabinol | Delta(9)-tetrahydrocannabinol : A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. The principal psychoactive constituent of the cannabis plant, it is used for treatment of anorexia associated with AIDS as well as nausea and vomiting associated with cancer chemotherapy. Dronabinol: A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic |
arachidonic acid | arachidonate : A long-chain fatty acid anion resulting from the removal of a proton from the carboxy group of arachidonic acid. icosa-5,8,11,14-tetraenoic acid : Any icosatetraenoic acid with the double bonds at positions 5, 8, 11 and 14. | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
orlistat | orlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug. Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity. | beta-lactone; carboxylic ester; formamides; L-leucine derivative | anti-obesity agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor |
arachidonyltrifluoromethane | AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 | fatty acid derivative; ketone; olefinic compound; organofluorine compound | EC 3.1.1.4 (phospholipase A2) inhibitor |
amentoflavone | biflavonoid; hydroxyflavone; ring assembly | angiogenesis inhibitor; antiviral agent; cathepsin B inhibitor; P450 inhibitor; plant metabolite | |
ochnaflavone | ochnaflavone : A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. ochnaflavone: from Lonicera japonica; structure given in first source | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
efipladib | efipladib: structure in first source | ||
methyl arachidonylfluorophosphonate | phosphonic ester | ||
pyrrophenone | pyrrophenone: structure in first source |